IMAC Holdings Completes First Infusion of Stem Cells in Clinical Study for the Treatment of Bradykinesia Due to Parkinson’s Disease

IMAC Holdings Completes First Infusion of Stem Cells in Clinical Study for the Treatment of Bradykinesia Due to Parkinson’s Disease
IMAC Holdings, Inc. (NASDAQ:IMAC) ("IMAC" or the "Company"), a provider of innovative medical advancements and ... read more
Source: Bing NewsPublished on 2020-12-30